7. References

ACGIH (2001) Documentation of the Threshold Limit Values and Biological Exposure Indices, 7^th Ed., American Conference of Governmental Industrial Hygienists. Cincinnati, OH.

Adams SP, Laws GM, Storer RD, et al. Detection of DNA damage induced by human carcinogens in acellular assays: potential application for determining genotoxic mechanisms. Mutat Res. 1996;368:235–248. PMID:8692229. [PubMed: 8692229]

Akyüz M, Ata S. Determination of aromatic amines in hair dye and henna samples by ion-pair extraction and gas chromatography-mass spectrometry. J Pharm Biomed Anal. 2008;47:68–80. PMID:18280687. [PubMed: 18280687]

Allen MJ, Boyland E, Dukes CE, et al. Cancer of the urinary bladder induced in mice with metabolites of aromatic amines and tryptophan. Br J Cancer. 1957;11:212–228. PMID:13460145. [PMC free article: PMC2073743] [PubMed: 13460145]

Axtell CD, Ward EM, McCabe GP, et al. Underlying and multiple cause mortality in a cohort of workers exposed to aromatic amines. Am J Ind Med. 1998;34:506–511. PMID:9787856. [PubMed: 9787856]

Baker RS, Bonin AM, Stupans I, Holder GM. Comparison of rat and guinea pig as sources of the S9 fraction in the Salmonella/mammalian microsome mutagenicity test. Mutat Res. 1980;71:43–52. PMID:6993931. [PubMed: 6993931]

Beland FA, Beranek DT, Dooley KL, et al. Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ Health Perspect. 1983;49:125–134. PMID:6339219. [PMC free article: PMC1569140] [PubMed: 6339219]

Beland FA, Kadlubar FF. Formation and persistence of arylamine DNA adducts in vivo. Environ Health Perspect. 1985;62:19–30. PMID:4085422. [PMC free article: PMC1568675] [PubMed: 4085422]

Billiard-Duchesne JL. [Occupation tumors of the bladder in France. Statistics-remarks.] Acta Unio Int Contra Cancrum. 1960;16:284–288. PMID:13800701. [PubMed: 13800701]

Bock-Hennig BS, Ullrich D, Bock KW. Activating and inactivating reactions controlling 2-naphthylamine mutagenicity. Arch Toxicol. 1982;50:259–266. PMID:7149991. [PubMed: 7149991]

Bonser GM. Epithelial tumours of the bladder in dogs induced by pure b-naphthylamine. J Path Bacteriol. 1943;55:1–6.

Bonser GM, Bradshaw L, Clayson DB, Jull JW. A further study of the carcinogenic properties of ortho hydroxy-amines and related compounds by bladder implantation in the mouse. Br J Cancer. 1956c;10:539–546. PMID:13396105. [PMC free article: PMC2073824] [PubMed: 13396105]

Bonser GM, Clayson DB, Jull JW. An experimental inquiry into the cause of industrial bladder cancer. Lancet. 1951;258:286–288. [PubMed: 14862177]

Bonser GM, Clayson DB, Jull JW. The induction of tumours of the subcutaneous tissues, liver and intestine in the mouse by certain dye-stuffs and their intermediates. Br J Cancer. 1956b;10:653–667. PMID:13426377. [PMC free article: PMC2073864] [PubMed: 13426377]

Bonser GM, Clayson DB, Jull JW, Pyrah LN. The carcinogenic properties of 2-amino-1-naphthol hydrochloride and its parent amine 2-naphthylamine. Br J Cancer. 1952;6:412–424. PMID:13032313. [PMC free article: PMC2007854] [PubMed: 13032313]

Bonser GM, Clayson DB, Jull JW, Pyrah LN. The carcinogenic activity of 2-naphthylamine. Br J Cancer. 1956a;10:533–538. PMID:13396104. [PMC free article: PMC2073828] [PubMed: 13396104]

Boyd JA, Eling TE. Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine. Cancer Res. 1987;47:4007–4014. PMID:3111680. [PubMed: 3111680]

Boyland E. The biochemistry of cancer of the bladder. Br Med Bull. 1958;14:153–158. PMID:13536378. [PubMed: 13536378]

Boyland E, Busby ER, Dukes CE, et al. Further experiments on implantation of materials into the urinary bladder of mice. Br J Cancer. 1964;13:575–581. PMID:14219552. [PMC free article: PMC2071086] [PubMed: 14219552]

Boyland E, Dukes CE, Grover PL. Carcinogenicity of 2-naphthylhydroxylamine and 2-naphthylamine. Br J Cancer. 1963;17:79–84. PMID:14014726. [PMC free article: PMC2071273] [PubMed: 14014726]

Boyland E, Kinder CH, Manson D. The biochemistry of aromatic amines. 8. Synthesis and detection of di-(2-amino-1-naphthyl) hydrogen phosphate, a metabolite of 2-naphthylamine in dogs. Biochem J. 1961;78:175–179. PMID:16748865. [PMC free article: PMC1205192] [PubMed: 16748865]

Boyland E, Manson D. The biochemistry of aromatic amines. The metabolism of 2-naphthylamine and 2-naphthylhydroxylamine derivatives. Biochem J. 1966;101:84–102. PMID:5971797. [PMC free article: PMC1270069] [PubMed: 5971797]

Budnick LD, Logue JN, Sokal DC, et al. Cancer and birth defects near the Drake Superfund site, Pennsylvania. Arch Environ Health. 1984;39:409–413. PMID:6524960. [PubMed: 6524960]

Bulbulyan MA, Figgs LW, Zahm SH, et al. Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol. 1995;24:266–275. PMID:7635585. [PubMed: 7635585]

Butler MA, Guengerich FP, Kadlubar FF. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res. 1989a;49:25–31. PMID:2908851. [PubMed: 2908851]

Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA. 1989b;86:7696–7700. PMID:2813353. [PMC free article: PMC298137] [PubMed: 2813353]

Case RA, Pearson JT. 1954 Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. II. Further consideration of the role of aniline and of the manufacture of auramine and magenta (fuchsine) as possible causative agents 2Br J Ind Med 11 213 216 PMID:13182161. [PMC free article: PMC1037558] [PubMed: 13182161]

Case RAM, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med. 1954;11:75–104. PMID:13149741. [PMC free article: PMC1037533] [PubMed: 13149741]

Cassidy LD, Youk AO, Marsh GM. The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine. Am J Ind Med. 2003;44:282–290. PMID:12929148. [PubMed: 12929148]

Chauhan PS, Neuhäaus A, Ehling UH. Induction of presumed somatic gene mutations in mice by 2-naphthylamine. Mutat Res. 1983;121:267–272. PMID:6621590. [PubMed: 6621590]

Chemical Sources International (2010) ChemSources database, [http://db2​.chemsources.com]

Conzelman GM Jr, Moulton JE. Dose-response relationships of the bladder tumorigen 2-naphthylamine: a study in beagle dogs. J Natl Cancer Inst. 1972;49:193–205. PMID:5037435. [PubMed: 5037435]

Conzelman GM Jr, Moulton JE, Flanders LE 3rd, et al. Induction of transitional cell carcinomas of the urinary bladder in monkeys fed 2-naphthylamine. J Natl Cancer Inst. 1969;42:825–836. PMID:4977557. [PubMed: 4977557]

Decarli A, Peto J, Piolatto G, La Vecchia C. Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis. Br J Cancer. 1985;51:707–712. PMID:3994914. [PMC free article: PMC1977059] [PubMed: 3994914]

Deichmann WB, Radomski JL. Carcinogenicity and metabolism of aromatic amines in the dog. J Natl Cancer Inst. 1969;43:263–269. PMID:4307704. [PubMed: 4307704]

Delzell E, Macaluso M, Cole P. A follow-up study of workers at a dye and resin manufacturing plant. J Occup Med. 1989;31:273–278. PMID:2918413. [PubMed: 2918413]

Doherty L. GC/MS analysis of forbidden amine carcinogens in 20 textiles and consumption good, and amine carcinogens appeared in environmental monitoring of textile treatment wastewater. Huanjing Huaxue. 2005;24:622–625.

Duverger-van Bogaert M, Crutzen-Fayt MC, Stecca C. Activation of some aromatic amines to mutagenic products by human red blood cell cytosol. Mutat Res. 1991;263:249–255. PMID:1861690. [PubMed: 1861690]

European Commission (1998) Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work (fourteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC)

European Commission (2002) Directive 2002/61/EC of the European Parliament and of the Council of 19 July 2002 amending for the nineteenth time Council Directive 76/769/EEC relating to restrictions on the marketing and use of certain dangerous substances and preparations (azocolourants)

European Commission (2004a) Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (Sixth individual Directive within the meaning of Article 16(1) of Council Directive 89/391/EEC) (codified version)

European Commission (2004b) Commission Directive 2004/93/EC of 21 September 2004 amending Council Directive 76/768/EEC for the purpose of adapting its Annexes II and III to technical progress.

European Commission (2005) Directive 2005/90/EC of the European Parliament and of the Council of 18 January 2006 amending, for the 29th time, Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (substances classified as carcinogenic, mutagenic or toxic to reproduction — c/m/r.

European Commission Community (1989) Council Directive 89/677/EEC of 21 December 1989 amending for the eighth time Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the member states relating to restrictions on the marketing and use of certain dangerous substances and preparations.

Felknor SA, Delclos GL, Lerner SP, et al. Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamine. J Occup Environ Med. 2003;45:289–294. PMID:12661186. [PubMed: 12661186]

Flückiger-Isler S, Baumeister M, Braun K, et al. Assessment of the performance of the Ames II assay: a collaborative study with 19 coded compounds. Mutat Res. 2004;558:181–197. PMID:15036131. [PubMed: 15036131]

GESTIS (2007) International limit values for chemical agents, BG Institute for Occupational Safety and Health, Sankt Augustin. Available at: http://www​.dguv.de/fa​/en/gestis/limit_values/index.jsp (accessed 20/04/10)

Goldwater LJ, Rosso AJ, Kleinfeld M. Bladder tumors in a coal tar dye plant. Arch Environ Health. 1965;11:814–817. PMID:5846076. [PubMed: 5846076]

Grimmer G, Dettbarn G, Seidel A, Jacob J. Detection of carcinogenic aromatic amines in the urine of non-smokers. Sei Total Environ. 2000;247:81–90. PMID:10721145. [PubMed: 10721145]

Gupta RS, Singh B. Mutagenic responses of five independent genetic loci in CHO cells to a variety of mutagens. Development and characteristics of a mutagen screening system based on selection for multiple drug-resistant markers. Mutat Res. 1982;94:449–466. PMID:7110183. [PubMed: 7110183]

Hadidian Z, Fredrickson TN, Weisburger EK, et al. Tests for chemical carcinogens. Report on the activity of derivatives of aromatic amines, nitrosamines, quinolines, nitroalkanes, amides, epoxides, aziridines, and purine antimetabolites. J Natl Cancer Inst. 1968;41:985–1036. PMID:5686039. [PubMed: 5686039]

Hamasaki T, Aramaki K, Hida T, et al. [Clinical study of occupational uroepithelial cancer] J UOEH. 1996;18:247–259. PMID:8981648. [PubMed: 8981648]

Hammons GJ, Guengerich FP, Weis CC, et al. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res. 1985;45:3578–3585. PMID:4016738. [PubMed: 4016738]

Hansen AM, Omland O, Poulsen OM, et al. Correlation between work process-related exposure to polycyclic aromatic hydrocarbons and urinary levels of alpha-naphthol, beta-naphthylamine and 1-hydroxypyrene in iron foundry workers. Int Arch Occup Environ Health. 1994;65:385–394. PMID:8034363. [PubMed: 8034363]

Harrison LH, Cox CE, Banks KW, Boyce WH. Distant metastases from beta-naphthylamine induced vesical tumors in dogs. J Urol. 1969;102:586–589. PMID:5347766. [PubMed: 5347766]

Hashmi AH, Naqvi AA, Rizvi AH. Analysis of known risk factors for bladder cancer in Pakistani population. J Pak Med Assoc. 1995;45:41–42. PMID:7602742. [PubMed: 7602742]

Hauri U, Lutolf B, Schlegel U, et al. Determination of carcinogenic aromatic amines in dyes, cosmetics, finger paints and inks for pens and tattoos with LC/MS. Mitt Lebensm Hyg. 2005;96:321–335.

Hellmér L, Bolcsfoldi G. An evaluation of the E. coli K-12 uvrB/recA DNA repair host-mediated assay. II. In vivo results for 36 compounds tested in the mouse. Mutat Res. 1992;272:161–173. PMID:1383748. [PubMed: 1383748]

Henson AF, Somerville AR, Farquharson ME, Goldblatt MW. Metabolism of bladder carcinogens; the metabolic path of 2-[8-14C]naphthylamine in the rat. Biochem J. 1954;58:383–389. PMID:13208626. [PMC free article: PMC1269910] [PubMed: 13208626]

Hicks RM, Chowaniec J. The importance of synergy between weak carcinogens in the induction of bladder cancer in experimental animals and humans. Cancer Res. 1977;37:2943–2949. PMID:872124. [PubMed: 872124]

Hicks RM, Wright R, Wakefield JS. The induction of rat bladder cancer by 2-naphthylamine. Br J Cancer. 1982;46:646–661. PMID:7138770. [PMC free article: PMC2011196] [PubMed: 7138770]

Hix C, Oglesby L, MacNair P, et al. Bovine bladder and liver cell and homogenate-mediated mutagenesis of Salmonella typhimurium with aromatic amines. Carcinogenesis. 1983;4:1401–1407. PMID:6357520. [PubMed: 6357520]

HSDB (2003) Hazardous Substances Data Base, available at: http://www​.nlm.nih.gov​/pubs/factsheets/hsdbfs.html (accessed 25/03/10).

Hueper WC, Wiley FH, Wolfe HD. Experimental production of bladder tumors in dogs by administration of beta-nathylamine. J Ind Hyg Toxicol. 1938;20:46–84.

Hyodo T, Maruta Y, Itaya H, et al. Evaluation of functional relationships for predicting mainstream smoke constituent machine yields for conventional cigarettes from the Japanese market. Regul Toxicol Pharmacol. 2007;48:194–224. PMID:17502123. [PubMed: 17502123]

IARC. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. IARC Monogr Eval Carcinog Risk Chem Man. 1974;4:1–286.

IARC 1978 Some aromatic amines and related nitro compounds - hair dyes, colouring agents and miscellaneous industrial chemicals IARC Monogr Eval Carcinog Risk Chem Man 16 1 400.

IARC. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl. 1987;7:1–440. PMID:3482203. [PubMed: 3482203]

IARC. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1–1438. PMID:15285078. [PMC free article: PMC4781536] [PubMed: 15285078]

Imaoka S, Yoneda Y, Matsuda T, et al. Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa. Biochem Pharmacol. 1997;54:677–683. PMID:9310344. [PubMed: 9310344]

Japan Society for Occupational Health (2007). Recommendation of occupational exposure limits (2007–2008). J Occup Health, 49:328–344. PMID:17708058. [PubMed: 17708058]

Kirlin WG, Trinidad A, Yerokun T, et al. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol. Cancer Res. 1989;49:2448–2454. PMID:2784998. [PubMed: 2784998]

Lide DR, editor (2008) CRC Handbook of Chemistry and Physics, 98th Ed., Boca Raton, FL, CRC Press, p. 3–384.

Loos R, Hanke G, Eisenreich SJ. Multi-component analysis of polar water pollutants using sequential solid-phase extraction followed by LC-ESI-MS. J Environ Monit. 2003;5:384–394. PMID:12833980. [PubMed: 12833980]

Lüersen L, Wellner T, Koch HM, et al. Penetration of beta-naphthylamine and o-toluidine through human skin in vitro. Arch Toxicol. 2006;80:644–646. PMID:16596380. [PubMed: 16596380]

MAK (2007) List of MAK and BAT Values 2007. Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Report No. 43, Deutsche Forschungsgemeinschaft, Weinheim, Wiley-VCH Verlag GmbH & Co. KGaA.

Mancuso TF, el-Attar AA. Cohort study of workers exposed to betanaphthylamine and benzidine. J Occup Med. 1967;9:277–285. PMID:6026374. [PubMed: 6026374]

Marsh GM, Cassidy LD. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening. Am J Ind Med. 2003;43:142–148. PMID:12541268. [PubMed: 12541268]

Mason TJ, Prorok PC, Neeld WE Jr, Vogler WJ. Screening for bladder cancer at the Du Pont Chambers Works: initial findings. J Occup Med. 1986;28:1011–1016. PMID:3772535. [PubMed: 3772535]

Mason TJ, Vogler WJ. Bladder cancer screening at the Dupont Chambers Works: a new initiative. J Occup Med. 1990;32:874–877. PMID:2074511. [PubMed: 2074511]

Mason TJ, Walsh WP, Lee K, Vogler W. New opportunities for screening and early detection of bladder cancer. J Cell Biochem Suppl. 1992;16I:13–22. PMID:1305676. [PubMed: 1305676]

Masuda Y, Mori K, Kuratsune M. Studies on bladder carcinogens in the human environment. I. Naphthylamines produced by pyrolysis of amino acids. Int J Cancer. 1967;2:489–493. PMID:6081591. [PubMed: 6081591]

Mayer VW. Genetic effects of naphthylamines. Mutat Res. 1982;99:349–369. PMID:6757743. [PubMed: 6757743]

Mirkova E, Ashby J. Activity of the human carcinogens benzidine and 2-naphthylamine in male mouse bone marrow micronucleus assays. Mutagenesis. 1988;3:437–439. PMID:3070279. [PubMed: 3070279]

Miyakawa M, Tachibana M, Miyakawa A, et al. Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan. Int J Urol. 2001;8:423–430. PMID:11555006. [PubMed: 11555006]

Moore BP, Potter PM, Hicks RM. Metabolism of 2-naphthylamine and benzidine by rat and human bladder organ cultures. Carcinogenesis. 1984;5:949–954. PMID:6733857. [PubMed: 6733857]

Morinaga K, Oshima A, Hara I. Multiple primary cancers following exposure to benzidine and beta-naphthylamine. Am J Ind Med. 1982;3:243–246. PMID:7171086. [PubMed: 7171086]

Morinaga K, Yutani S, Hara I. [Cancer mortality of male workers exposed to benzidine and/or beta-naphthylamine] Nippon Eiseigaku Zasshi. 1990;45:909–918. PMID:2089166. [PubMed: 2089166]

Naito S, Tanaka K, Koga H, et al. Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study. Cancer. 1995;76:1445–1452. PMID:8620422. [PubMed: 8620422]

Nakamura J, Takamatsu M, Doi J, et al. [Clinical study on the occupational urinary tract tumor in Wakayama (author’s transl)] Nippon Hinyokika Gakkai Zasshi. 1980;71:945–951. PMID:7431721. [PubMed: 7431721]

Narvekar MS, Srivastava AK. Separation of banned amine isomers in relation to German Ban on azo dyes by derivatization on GC-MS. Chromatographia. 2002;55:729–735.

NIOSH (2005) NIOSH Pocket Guide to Chemical Hazards, NIOSH Publication No. 2005-149 http://www​.cdc.gOv/niosh/npg/nengapdx​.html#a.

NTP (2005) 2-Naphthylamine CAS No. 91–59–8, Report on Carcinogens, Eleventh Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program http://ntp​.niehs.nih​.gov/ntp/roc/eleventh/profiles/s117naph​.pdf.

O’Neil MJ, editor (2006) The Merck Index, 14th Ed., Whitehouse Station, NJ Merck & Co., Inc., p. 1107.

Oda Y. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system. Mutat Res. 2004;554:399–406. PMID:15450435. [PubMed: 15450435]

Oda Y, Aryal P, Terashita T, et al. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase. Mutat Res. 2001;492:81–90. PMID:11377247. [PubMed: 11377247]

Oglesby LA, Hix C, Snow L, et al. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium. Cancer Res. 1983;43:5194–5199. PMID:6352016. [PubMed: 6352016]

Parodi S, Taningher M, Russo P, et al. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity. Carcinogenesis. 1981;2:1317–1326. PMID:7034987. [PubMed: 7034987]

Phillipson CE, Ioannides C. Activation of aromatic amines to mutagens by various animal species including man. Mutat Res. 1983;124:325–336. PMID:6361543. [PubMed: 6361543]

Piolatto G, Negri E, La Vecchia C, et al. Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis. Br J Cancer. 1991;63:457–459. PMID:2003988. [PMC free article: PMC1971871] [PubMed: 2003988]

Poupko JM, Radomski T, Santella RM, Radomski JL. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines. J Natl Cancer Inst. 1983;70:1077–1080. PMID:6574277. [PubMed: 6574277]

Purchase IF, Kalinowski AE, Ishmael J, et al. Lifetime carcinogenicity study of 1- and 2-naphthylamine in dogs. Br J Cancer. 1981;44:892–901. PMID:7326199. [PMC free article: PMC2010866] [PubMed: 7326199]

Radomski JL, Brill E. The role of N-oxidation products of aromatic amines in the induction of baldder cancer in the dog. Arch Toxikol. 1971;28:159–175. PMID:5126459. [PubMed: 5126459]

Radomski JL, Brill E, Deichmann WB, Glass EM. Carcinogenicity testing of N-hydroxy and other oxidation and decomposition products of 1- and 2-naphthylamine. Cancer Res. 1971;31:1461–1467. PMID:4328736. [PubMed: 4328736]

Radomski JL, Radomski T, MacDonald WE. Cocarcinogenic interaction between D,L-tryptophan and 4-aminobiphenyl or 2-naphthylamine in dogs. Nippon Geka Hokan. 1977;58:1831–1834. PMID:864760. [PubMed: 864760]

Radomski JL, Rey AA, Brill E. Conjugates of the N-hydroxy metabolites of aromatic amines in dog urine. Proc Am Assoc Cancer Res. 1973;14:126.

Rdomski JL, Krischer C, Krischer KN. Histologic and histochemical preneoplastic changes in the bladder mucosae of dogs given 2-naphthylamine. J Natl Cancer Inst. 1978;60:327–333. PMID:621752. [PubMed: 621752]

Riedel K, Scherer G, Engl J, et al. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol. 2006;30:187–195. PMID:16803653. [PubMed: 16803653]

Riffelmann M, Müller G, Schmieding W, et al. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int Arch Occup Environ Health. 1995;68:36–43. PMID:8847111. [PubMed: 8847111]

Rigotti E, Fontana D, Negri GL, et al. [Results of hyperthermia on the bladder carcinomas of the dog (author’s transl)] J Urol Nephrol (Paris). 1977;83:175–184. PMID:853554. [PubMed: 853554]

Roe FJ, Mitchley BC, Walters M. Tests for carcinogenesis using newborn mice: 1,2-benzanthracene, 2-naphthylamine, 2-naphthylhydroxylamine and ethyl methane sulphonate. Br J Cancer. 1963;17:255–260. PMID:14042726. [PMC free article: PMC2070986] [PubMed: 14042726]

Romanenko AM, Martynenko AG. [Morphology of bladder neoplasms induced by beta-naphthylamine in dogs] Vopr Onkol. 1972;18:70–75. PMID:4345575. [PubMed: 4345575]

Rubino GF, Scansetti G, Piolatto G, Pira E. The carcinogenic effect of aromatic amines: an epidemiological study on the role of o-toluidine and 4,4′-methylene bis (2-methylaniline) in inducing bladder cancer in man. Environ Res. 1982;27:241–254. PMID:7084156. [PubMed: 7084156]

Saffiotti U, Cefis F, Montesano R et al. (1967) Induction of bladder cancer in hamsters fed aromatic amines. In: Deichmann W, Lampe KF (eds) Bladder Cancer: a symposium. 129–135.

Sasaki JC, Fellers RS, Colvin ME. Metabolic oxidation of carcinogenic arylamines by p450 monooxygenases: theoretical support for the one-electron transfer mechanism. Mutat Res. 2002;506–507:79–89. [PubMed: 12351147]

Schulte PA, Ringen K, Hemstreet GP, et al. Risk assessment of a cohort exposed to aromatic amines. Intial results. J Occup Med. 1985;27:115–121. PMID:3884754. [PubMed: 3884754]

Schulte PA, Ringen K, Hemstreet GP, et al. Risk factors for bladder cancer in a cohort exposed to aromatic amines. Cancer. 1986;58:2156–2162. PMID:3756832. [PubMed: 3756832]

Shimada T, Hayes CL, Yamazaki H, et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996;56:2979–2984. PMID:8674051. [PubMed: 8674051]

Shinka T, Sawada Y, Morimoto S, et al. Clinical study on urothelial tumors of dye workers in Wakayama City. J Urol. 1991;146:1504–1507. PMID:1942328. [PubMed: 1942328]

Stabbert R, Schäfer KH, Biefel C, Rustemeier K. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom. 2003;17:2125–2132. PMID:12955743. [PubMed: 12955743]

Stern FB, Murthy LI, Beaumont JJ, et al. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines, III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States. J Occup Med. 1985;27:495–500. PMID:4032086. [PubMed: 4032086]

Stoner GD, Conran PB, Greisiger EA, et al. Comparison of two routes of chemical administration on the lung adenoma response in strain A/J mice. Toxicol Appl Pharmacol. 1986;82:19–31. PMID:3945940. [PubMed: 3945940]

Szeszenia-Dabrowska N, Wilczyńska U, Kaczmarek T, Szymczak W. Cancer mortality among male workers in the Polish rubber industry. Pol J Occup Med Environ Health. 1991;4:149–157. PMID:1799640. [PubMed: 1799640]

Takemura N, Akiyama T, Nakajima C. A survey of the pollution of the Sumida River, especially on the aromatic amines in the water. Air Water Pollut. 1965;9:665–670. PMID:5837729. [PubMed: 5837729]

Talukder M, Kates CR (2000) Naphthalene derivatives. In: Kirk-Othmer Encyclopaedia of Chemical Technology. doi:10.1002/0471238961.1401160820011221.a01.

Theiss JC, Shimkin MB, Weisburger EK. Pulmonary adenoma response of strain A mice to sulfonic acid derivatives of 1- and 2-naphthylamines. J Natl Cancer Inst. 1981;67:1299–1302. PMID:6947112. [PubMed: 6947112]

Troll W, Nelson N. N-hydroxy-2-naphthylamine, a urinary metabolite of 2-naphthylamine inman and dog. Fed Proc. 1961;20:41.

Troll W, Tessler AN, Nelson N. Bis (2-amino-1-naphthyl) phosphate, a metabolite of beta-naphthylamine in human urine. J Urol. 1963;89:626–627. PMID:13994249. [PubMed: 13994249]

Tsuchiya K, Okubo T, Ishizu S. An epidemiological study of occupational bladder tumours in the dye industry of Japan. Br J Ind Med. 1975;32:203–209. PMID:1156568. [PMC free article: PMC1008059] [PubMed: 1156568]

Tsuji I. Environmental and industrial cancer of the bladder in Japan. Acta Unio Int Contra Cancrum. 1962;18:662–666. [PubMed: 13994539]

UN/UNEP/FAO (2007) Chemical Review Committee (CRC) 1. Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade. Notifications of Final Regulatory Actions by chemical name. [http://www​.pic.int/home​.php?type=b&id​=7&sid=18&tid=42]

Verschueren K (2001) Handbook of Environmental Data on Organic Chemicals, 4th Ed., New York, John Wiley & Sons, Inc., pp. 1593.

Veys CA. Two epidemiological inquiries into the incidence of bladder tumors in industrial workers. J Natl Cancer Inst. 1969;43:219–226. PMID:5796383. [PubMed: 5796383]

Veys CA. Bladder tumours in rubber workers: a factory study 1946–1995. Occup Med (Lond). 2004;54:322–329. PMID:15289589. [PubMed: 15289589]

Vigliani EC, Barsotti M. Environmental tumors of the bladder in some Italian dye-stuff factories. Acta Unio Int Contra Cancrum. 1962;18:669–675. PMID:13997151. [PubMed: 13997151]

Walters MA, Roe FJ, Mitchley BC, Walsh A. Further tests for carcinogenesis using newborn mice: 2-naphthylamine, 2-naphthylhydroxylamine, 2-acetylaminofluorene and ethyl methane sulphonate. Br J Cancer. 1967;21:367–372. PMID:6028088. [PMC free article: PMC2008108] [PubMed: 6028088]

Weiss T, Angerer J. Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;778:179–192. PMID:12376125. [PubMed: 12376125]

Weiss T, Brüning T, Bolt HM. Dephenylation of the rubber chemical N-phenyl-2-naphthylamine to carcinogenic 2-naphthylamine: a classical problem revisited. Crit Rev Toxicol. 2007;37:553–566. PMID:17674211. [PubMed: 17674211]

Wise RW, Zenser TV, Kadlubar FF, Davis BB. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res. 1984;44:1893–1897. PMID:6424934. [PubMed: 6424934]

Yamazoe Y, Miller DW, Weis CC, et al. DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis. 1985;6:1379–1387. PMID:3928186. [PubMed: 3928186]

Yoshida M, Numoto S, Otsuka H. Histopathological changes induced in the urinary bladder and liver of female BALB/c mice treated simultaneously with 2-naph-thylamine and cyclophosphamide. Gann. 1979;70:645–652. PMID:520755. [PubMed: 520755]

Zima J, Dejmkova H, Barek J. HPLC determination of naphthalene amino derivatives using electrochemical detection at carbon paste electrodes. Electroanalysis. 2007;19:185–190.